Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Celldex Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 11
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Kolltan Pharma Raises US$60 Million In Series D Financing 14
Kolltan Pharma Raises US$25 Million In Series C Financing 16
Partnerships 17
Celldex Therapeutics Enters into Agreement with Roche 17
Licensing Agreements 18
Shanghai Henlius Biotech Enters into Licensing Agreement with Kolltan Pharma for KTN0216 18
Kolltan Pharma Enters into Licensing Agreement with Spirogen 19
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 20
Kolltan Pharma Enters Into Licensing Agreement With MedImmune 21
Kolltan Pharma Enters Into Licensing And Research Agreement With Children’s Hospital of Philadelphia For Pediatric Neuroblastoma Therapies 22
Equity Offering 23
Celldex Therapeutics Files Registration Statement for Public Offering of Shares 23
Celldex Therapeutics to Raise up to USD48.8 Million in Final Tranche of Public Offering of Shares 24
Celldex Therapeutics Raises USD200 Million in Public Offering of Shares 25
Kolltan Pharma Withdraws IPO 27
Celldex Therapeutics Completes Public Offering Of Shares For US$191.4 Million 28
Celldex Therapeutics Completes Public Offering Of Shares For US$104 Million 30
Celldex Therapeutics Completes Second Tranche Of Private Placement Of Shares For US$7.3 Million 32
Celldex Therapeutics Completes Third Tranche Of Private Placement Of Shares For US$21 Million 33
Celldex Therapeutics Completes Underwriters’ Exercise Of Over-Allotment Option For US$46 Million 35
Acquisition 37
Celldex Therapeutics Acquires Kolltan Pharma 37
Kolltan Pharma Acquires Xetrios Therapeutics 38
Celldex Therapeutics Inc – Key Competitors 39
Celldex Therapeutics Inc – Key Employees 40
Celldex Therapeutics Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 43
Financial Announcements 43
Nov 07, 2018: Celldex provides corporate update and reports third quarter 2018 results 43
Aug 08, 2018: Celldex provides corporate update and reports second quarter 2018 results 45
May 10, 2018: Celldex Provides Corporate Update and Reports First Quarter 2018 Results 47
Mar 07, 2018: Celldex Provides Corporate Update and Reports Full Year 2017 Results 50
Nov 07, 2017: Celldex Reports Third Quarter 2017 Results 52
Aug 08, 2017: Celldex Reports Second Quarter 2017 Results 56
May 09, 2017: Celldex Reports First Quarter 2017 Results 58
Mar 14, 2017: Celldex Provides Corporate Update and Reports Full Year 2016 Results 60
Corporate Communications 62
Oct 03, 2017: Celldex Therapeutics Appoints Margo Heath-Chiozzi, M.D., as Senior Vice President, Regulatory Affairs 62
Sep 12, 2017: Celldex Announces Departure of Chief Medical Officer 63
Jun 16, 2017: Celldex Therapeutics Announces Additions to the Board of Directors and Senior Management Team 64
Mar 01, 2017: Celldex Therapeutics Announces Appointment to Board of Directors 65
Clinical Trials 66
Apr 20, 2018: Celldex Therapeutics presents data on CDX-1140 at AACR Annual Meeting 2018 66
Nov 30, 2017: Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors 67
May 17, 2017: Celldex Therapeutics to Present Clinical Results from Phase 2 Study of Glembatumumab Vedotin at 2017 ASCO Annual Meeting 68
Appendix 69
Methodology 69
About GlobalData 69
Contact Us 69
Disclaimer 69
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Celldex Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Celldex Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 11
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Kolltan Pharma Raises US$60 Million In Series D Financing 14
Kolltan Pharma Raises US$25 Million In Series C Financing 16
Celldex Therapeutics Enters into Agreement with Roche 17
Shanghai Henlius Biotech Enters into Licensing Agreement with Kolltan Pharma for KTN0216 18
Kolltan Pharma Enters into Licensing Agreement with Spirogen 19
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 20
Kolltan Pharma Enters Into Licensing Agreement With MedImmune 21
Kolltan Pharma Enters Into Licensing And Research Agreement With Children's Hospital of Philadelphia For Pediatric Neuroblastoma Therapies 22
Celldex Therapeutics Files Registration Statement for Public Offering of Shares 23
Celldex Therapeutics to Raise up to USD48.8 Million in Final Tranche of Public Offering of Shares 24
Celldex Therapeutics Raises USD200 Million in Public Offering of Shares 25
Kolltan Pharma Withdraws IPO 27
Celldex Therapeutics Completes Public Offering Of Shares For US$191.4 Million 28
Celldex Therapeutics Completes Public Offering Of Shares For US$104 Million 30
Celldex Therapeutics Completes Second Tranche Of Private Placement Of Shares For US$7.3 Million 32
Celldex Therapeutics Completes Third Tranche Of Private Placement Of Shares For US$21 Million 33
Celldex Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For US$46 Million 35
Celldex Therapeutics Acquires Kolltan Pharma 37
Kolltan Pharma Acquires Xetrios Therapeutics 38
Celldex Therapeutics Inc, Key Competitors 39
Celldex Therapeutics Inc, Key Employees 40
Celldex Therapeutics Inc, Other Locations 41
Celldex Therapeutics Inc, Subsidiaries 41
List of Figures
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Celldex Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Celldex Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 11